NVIV - InVivo Therapeutics Holdings Corp.
InVivo Therapeutics Holdings Corp.
One Kendall Square
4th Floor Suite B14402 Building 1400 West
Cambridge, MA 02139
United States
617 863 5500
https://www.invivotherapeutics.com
Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 6
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Richard M. Toselli | Pres, CEO, Chief Medical Officer & Director | 825.2k | N/A | 1958 |
| Mr. Richard C. Christopher | CFO & Treasurer | 537.82k | N/A | 1970 |
| Ms. Heather M. Hamel J.D. | Chief Legal Officer & Gen. Counsel | 446.96k | N/A | 1990 |
| Dr. Robert S. Langer Jr., Ph.D., Sc.D., SCD | Co-Founder & Member of Scientific Advisory Board | N/A | N/A | 1949 |
| Dr. Joseph Philip Vacanti | Co-Founder | N/A | N/A | 1949 |
Description
InVivo Therapeutics Holdings Corp. operates as a research and clinical-stage biomaterials and biotechnology company in the United States. The company engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant comprise of biocompatible and bioresorbable polymers, which includes Poly lactic-co-glycolic acid, a polymer which is widely used in resorbable sutures and provides the biocompatible support for Neuro-Spinal Scaffold implant; and Poly-L-Lysine, a positively charged polymer used to coat surfaces to promote cellular attachment. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.
Corporate Governance
InVivo Therapeutics Holdings Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
